CINCOR PHARMA INC (CINC)
US17240Y1091 - Common Stock
Noteworthy Wednesday Option Activity: CINC, ACIW, IDCC
CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat
WALTHAM, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor” or the “Company”) announced today completion of an End-of-Phase 2 meeting...
SHAREHOLDER ALERT: Weiss Law Reminds ARGO, OSH, CINC, and DCT Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CINC, DCT, ANGN, CEMI
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER ALERT: Weiss Law Reminds CINC, DCT, PAYA, and DCP Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TCFC, TIG, CINC, DCT
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER ALERT: Weiss Law Reminds CINC, DCT, PAYA, and DCP Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
SHAREHOLDER ALERT: Weiss Law Reminds LPTX, CNCE, ALBO, and CINC Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AQUA, CINC, ALBO, PAYA, GMGI
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Moore Kuehn Encourages GMGI, CINC, ALBO, and PAYA Investors to Contact Law Firm
/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...
SHAREHOLDER ALERT: Weiss Law Reminds ALBO, CINC, DCT, and PAYA Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
Why These Two Biotech Stocks Blasted Higher This Week
There's nothing like a big-premium buyout to send a company's share price to the moon.
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review
Sharp Tesla price cuts and some notable earnings were in focus.
AstraZeneca Stock Nabs Breakout After $1.8 Billion CinCor Buyout
CinCor will bolster AstraZeneca's growing cardio-renal business.
SHAREHOLDER ALERT: Weiss Law Investigates CinCor Pharma, Inc.
/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CinCor Pharma, Inc....
Hot Stocks: Crypto stocks rally; CINC, ALBO soar on M&A news; LULU slumps on guidance
Crypto stocks rallied, helped by a rise in Bitcoin. CINC and ALBO jumped on separate deals to be acquired. LULU dropped on guidance.
Noteworthy Monday Option Activity: ALBO, MSTR, CINC
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMYT, CINC, ALBO
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Shareholder Alert: Ademi LLP investigates whether CinCor Pharma, Inc. has obtained a Fair Price in its transaction with AstraZeneca
/PRNewswire/ -- Ademi LLP is investigating CinCor (Nasdaq: CINC) for possible breaches of fiduciary duty and other violations of law in its transaction with...
AstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion Deal
AstraZeneca stock wavered as it agreed to buy CinCor Pharma, maker of blood pressure drug baxdrostat for $1.8 billion. CINC stock soared.
Why Is CinCor (CINC) Stock Up 138% Today?
CinCor (CINC) stock is rocketing higher on Monday following news that AstraZeneca (AZN) is acquiring the company for up to $1.8 billion.
